Cargando…

Glucocorticoid sensitivity in Behçet's disease

OBJECTIVE: Glucocorticoid (GC) sensitivity is highly variable among individuals and has been associated with susceptibility to develop (auto-)inflammatory disorders. The purpose of the study was to assess GC sensitivity in Behçet's disease (BD) by studying the distribution of four GC receptor (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quax, R A M, van Laar, J A M, van Heerebeek, R, Greiner, K, Ben-Chetrit, E, Stanford, M, Wallace, G R, Fortune, F, Ghabra, M, Soylu, M, Hazes, J M W, Lamberts, S W J, Kappen, J H, van Hagen, P M, Koper, J W, Feelders, R A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioScientifica 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681319/ https://www.ncbi.nlm.nih.gov/pubmed/23781311 http://dx.doi.org/10.1530/EC-12-0056

Ejemplares similares

Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis
por: Quax, R. A. M., et al.
Publicado: (2015)

In vitro glucocorticoid sensitivity is associated with clinical glucocorticoid therapy outcome in rheumatoid arthritis
por: Quax, Rogier AM, et al.
Publicado: (2012)

Genome-Wide Association Study in an Admixed Case Series Reveals IL12A as a New Candidate in Behçet Disease
por: Kappen, Jasper H., et al.
Publicado: (2015)

Glucocorticoid receptor gene polymorphisms and disease activity during pregnancy and the postpartum period in rheumatoid arthritis
por: Quax, Rogier AM, et al.
Publicado: (2012)

Managing Behçet’s disease: An update on current and emerging treatment options
por: van Daele, P LA, et al.
Publicado: (2009)

Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis
por: van Oosten, Manon JM, et al.
Publicado: (2010)

Cytokines in the colon of a patient with Behçet's disease
por: Kappen, Jasper H, et al.
Publicado: (2009)

Do synovial biopsies help to support evidence for involvement of innate immunity in the immunopathology of Behçet's disease?
por: van Laar, Jan AM, et al.
Publicado: (2009)

Behçet's Disease Under Microbiotic Surveillance? A Combined Analysis of Two Cohorts of Behçet's Disease Patients
por: van der Houwen, Tim B., et al.
Publicado: (2020)

Efficacy and safety of selective glucocorticoid receptor modulators in comparison to glucocorticoids in arthritis, a systematic review
por: Safy, M., et al.
Publicado: (2017)

Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsis
por: van den Akker, Erica L. T., et al.
Publicado: (2009)

Leukocyte toll-like receptor expression in pathergy positive and negative Behçet’s disease patients
por: van der Houwen, Tim B, et al.
Publicado: (2020)

Behçet’s Disease: Do Natural Killer Cells Play a Significant Role?
por: Petrushkin, Harry, et al.
Publicado: (2015)

Peripheral glucocorticoid receptor antagonism by relacorilant with modest HPA axis disinhibition
por: Viho, Eva M G, et al.
Publicado: (2022)

Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review
por: Vincken, Nanette L A, et al.
Publicado: (2022)

Understanding heart failure with preserved ejection fraction: where are we today?
por: van Heerebeek, L., et al.
Publicado: (2016)

Circulating NK cells and their subsets in Behçet's disease
por: Hasan, M. S., et al.
Publicado: (2017)

Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease
por: Karim, A. F., et al.
Publicado: (2018)

Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells
por: Veenstra, Marije J., et al.
Publicado: (2016)

Behçet's disease presenting with mononeuritis multiplex [corrected]
por: Walker, L. J., et al.
Publicado: (1990)

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial
por: de Jong, P H, et al.
Publicado: (2014)

Arsenic alters the function of the glucocorticoid receptor as a transcription factor.
por: Kaltreider, R C, et al.
Publicado: (2001)

A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet’s Syndrome
por: Khan, E., et al.
Publicado: (2016)

Chromogranin A, Ki-67 index and IGF-related genes in patients with neuroendocrine tumors
por: van Adrichem, R C S, et al.
Publicado: (2013)

Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R/IL12RB2 regions associated with Behçet's disease
por: Remmers, Elaine F., et al.
Publicado: (2010)

Glucocorticoid receptor polymorphisms modulate cardiometabolic risk factors in patients in long-term remission of Cushing’s syndrome
por: Roerink, Sean H. P. P., et al.
Publicado: (2016)

Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss
por: Kaur, K, et al.
Publicado: (2009)

BDNF Val66Met genotype determines hippocampus-dependent behavior via sensitivity to glucocorticoid signaling
por: Notaras, M, et al.
Publicado: (2016)

Salvage peptide receptor radionuclide therapy with [(177)Lu-DOTA,Tyr(3)]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours
por: van der Zwan, W. A., et al.
Publicado: (2018)

Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade(®) to Remsima(®)? An Observational Study
por: Xue, Laixi, et al.
Publicado: (2020)

Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review
por: Ghalandari, N., et al.
Publicado: (2020)

The BDNF Val66Met polymorphism regulates glucocorticoid-induced corticohippocampal remodeling and behavioral despair
por: Notaras, M, et al.
Publicado: (2017)

Neuro-Behçets in a Child
por: Vesoulis, Zachary A., et al.
Publicado: (2014)

Cytoplasmic receptor levels and glucocorticoid response in human lymphoblastoid cell lines.
por: Bird, C. C., et al.
Publicado: (1975)

Diagnosis and treatment of uveitis; not restricted to the ophthalmologist
por: van Laar, Jan A. M., et al.
Publicado: (2015)

Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside.
por: Gledhill, R. M., et al.
Publicado: (1983)

Radiation of parotid or submandibular glands is effective for drooling in patients with parkinsonism; a randomised double-blind placebo-controlled trial
por: Steenbakkers, R.J.H.M., et al.
Publicado: (2022)

Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients
por: Neggers, Sebastian J. C. M. M., et al.
Publicado: (2011)

Glucocorticoids, stress and eating: The mediating role of appetite‐regulating hormones
por: Kuckuck, Susanne, et al.
Publicado: (2022)

Oral Health and Its Aetiological Role in Behçet's Disease
por: Mumcu, Gonca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b9qu23at98rq6rjsk4617dkkt1